Evidence map›Paper›PMID 24452062›Full record

ArticleNeuroscience2013

Activation of membrane estrogen receptors attenuates opioid receptor-like1 receptor-mediated antinociception via an ERK-dependent non-genomic mechanism.

K M Small, S Nag, S S Mokha

Abstract read
In one paragraph

Article in Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. ORLJournal of molecular neuroscience : MN · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. The dual action of estrogen hypothesis.Trends in neurosciences · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

K M SmallDepartment of Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208, USA.
S NagDepartment of Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208, USA.
S S MokhaDepartment of Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208, USA. Electronic address: smokha@mmc.edu.
Meharry Medical College · US

Funding

THE MEHARRY RISE INITIATIVER25GM059994 · NIGMS · MEHARRY MEDICAL COLLEGE · PI MOTLEY-JOHNSON, EVANGELINE D · 1999 to 2021
$23.0M
Meharry RCMI Program in Women's Health ResearchG12MD007586 · NIMHD · MEHARRY MEDICAL COLLEGE · PI HILDRETH, JAMES E · 2012 to 2016
$7.8M
CONTROL OF NOCICEPTION IN THE SPINAL CORDSC1NS078778 · NINDS · MEHARRY MEDICAL COLLEGE · PI MOKHA, SUKHBIR S · 2011 to 2014
$1.1M
NIGMS NIH HHS R25 GM059994NIGMS NIH HHS R25 GM59994NIMHD NIH HHS G12 MD007586NINDS NIH HHS SC1 NS078778NINDS NIH HHS SC1NS078778
6 · The paper itself

Abstract

To our knowledge, the present data are the first to demonstrate that activation of membrane estrogen receptors (mERs) abolishes opioid receptor-like 1 (ORL1) receptor-mediated analgesia via extracellular signal-regulated kinase (ERK)-dependent non-genomic mechanisms. Estrogen was shown previously to both attenuate ORL1-mediated antinociception and down-regulate the ORL1 gene expression. The present study investigated whether non-genomic mechanisms contribute to estrogen-induced attenuation of ORL1-mediated antinociception by the mERs GPR30, Gq-coupled mER, ERα, and ERβ. E2BSA [β-estradiol-6-(O-carboxymethyl)oxime: bovine serum albumin] (0.5mM), a membrane impermeant analog of estradiol, injected intrathecally immediately prior to orphanin FQ (OFQ;10 nmol), the endogenous ligand for the ORL1 receptor, abolished OFQ's antinociceptive effect in both male and ovariectomized (OVX) female rats, assessed using the heat-induced tail-flick assay. This effect was not altered by protein synthesis inhibitor, anisomycin (125 μg), given intrathecally 15 min prior to E2BSA and OFQ. Intrathecal application of selective receptor agonists permitted the relative contributions of various estrogen receptors in mediating this blockade of the antinociceptive response of OFQ. Activation of GPR30, Gq-mER, ERα, but not ERβ abolished ORL1-mediated antinociception in males and OVX females. E2BSA produced a parallel and significant increase in the phosphorylation of ERK 2 only in OVX females, and pre-treatment with MEK/ERK 1/2 inhibitor, U0126 (10 μg), blocked the mER-mediated abolition of ORL1-mediated antinociception in OVX females. Taken together, the data are consistent with the interpretations that mER activation attenuates ORL1-mediated antinociception through a non-genomic, ERK 2-dependent mechanism in females.

Indexed as

AnimalsBlotting, WesternCell MembraneExtracellular Signal-Regulated MAP KinasesFemaleMaleNociceptin ReceptorOvariectomyPainRatsRats, Sprague-DawleyReceptors, EstrogenReceptors, OpioidExtracellular Signal-Regulated MAP KinasesNociceptin ReceptorOprl1 protein, ratReceptors, EstrogenReceptors, Opioidanalysis of varianceANOVAarea under the curveAUCdiarylpropionitrileDPNE2BSAERKestrogen receptorextracellular signal-regulated kinaseGIRKGPR30G protein-gated inwardly rectifying potassium channelsGq-coupled mERGq-mERmembrane estrogen receptorsmERsOFQopiod receptor-like 1 (ORL1) receptoropioid receptor-like 1ORL1orphanin FQovariectomizedOVXpainPKAPKCPPTpropylpyrazoletriolprotein kinase Aprotein kinase Csex differencesspinal cordtail flick latenciesTFLβ-estradiol-6-(O-carboxymethyl)oxime: bovine serum albumin

Identifiers

PMID24452062
PMCPMC3900883
OpenAlexW2070337220

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.